Large-cap Consumer Staples company CVS Health has moved 0.7% so far today on a volume of 11,246,943, compared to its average of 7,575,538. In contrast, the S&P 500 index moved 1.0%.
CVS Health trades -15.11% away from its average analyst target price of $87.18 per share. The 22 analysts following the stock have set target prices ranging from $74.0 to $104.0, and on average have given CVS Health a rating of buy.
If you are considering an investment in CVS, you'll want to know the following:
-
CVS Health's current price is -22.4% below its Graham number of $95.42, which implies the stock has a margin of safety
-
CVS Health has moved -27.0% over the last year, and the S&P 500 logged a change of 17.0%
-
Based on its trailing earnings per share of 6.53, CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 11.3 while the S&P 500 average is 15.97
-
CVS has a forward P/E ratio of 8.7 based on its forward 12 month price to earnings (EPS) of $8.51 per share
-
The company has a price to earnings growth (PEG) ratio of 3.42 — a number near or below 1 signifying that CVS Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.28 compared to its sector average of 4.12
-
CVS Health Corporation provides health services in the United States.
-
Based in Woonsocket, the company has 219,000 full time employees and a market cap of $95.24 Billion. CVS Health currently returns an annual dividend yield of 3.2%.
